In MM, plasma cells reduce the levels of OPG in the bone marrow microenvironment.19 Possibly, the low number of malignant plasma cells that are present in AL amyloidosis cannot inhibit osteoblast function and cannot reduce the OPG level in the AL microenvironment, as in MM. The gene discussed is TNFRSF11B; the disease is Miyoshi myopathy.